Insmed Contingent Consideration Liability (Non-Current) decreased by 14.0% to $270.31M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 69.0%, from $159.90M to $270.31M.
An increase often indicates successful integration or high performance of acquired assets triggering earn-outs, while a decrease may signal missed targets or the settlement of obligations.
This represents the long-term portion of obligations to pay additional consideration to sellers in connection with past...
Standard for companies with active M&A strategies and earn-out structures in purchase agreements.
contingent_consideration_liability_noncurrent| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $76.49M | $75.67M | $66.12M | $55.60M | $51.80M | $51.10M | $38.60M | $46.40M | $69.90M | $84.60M | $63.70M | $101.50M | $157.60M | $144.20M | $159.90M | $180.50M | $259.60M | $314.34M | $270.31M |
| QoQ Change | — | -1.1% | -12.6% | -15.9% | -6.8% | -1.4% | -24.5% | +20.2% | +50.6% | +21.0% | -24.7% | +59.3% | +55.3% | -8.5% | +10.9% | +12.9% | +43.8% | +21.1% | -14.0% |
| YoY Change | — | — | — | — | -32.3% | -32.5% | -41.6% | -16.5% | +34.9% | +65.6% | +65.0% | +118.8% | +125.5% | +70.4% | +151.0% | +77.8% | +64.7% | +118.0% | +69.0% |